Literature DB >> 3945351

Peritoneal permeability to proteins in diabetic and non-diabetic continuous ambulatory peritoneal dialysis patients.

R T Krediet, F M Zuyderhoudt, E W Boeschoten, L Arisz.   

Abstract

Peritoneal permeability to proteins was measured in diabetic and non-diabetic continuous ambulatory peritoneal dialysis patients during peritonitis and control periods. Clearances of albumin, transferrin, IgG, C3 and alpha 2-macroglobulin appeared to decrease as molecular weight increased. This relationship could be described by a power curve fit. The decrease was more than could be explained by differences in free diffusion only, indicating a size-selective barrier in the peritoneum. For all measured proteins clearances were higher in the diabetic patients. This may reflect a generally increased permeability due to their microangiopathy. The largest increase in protein loss and protein clearances was found during peritonitis. Our results do not suggest increased local production of any of the investigated proteins during the inflammation. Therefore, an increase in either peritoneal permeability or effective surface area or both is the most likely explanation. It is concluded in this study that peritoneal protein clearances are dependent on their molecular weight and that they are proportionally increased in patients with diabetes and during peritonitis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3945351     DOI: 10.1159/000183652

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  13 in total

1.  The Mutual Relationship Between Peritonitis and Peritoneal Transport.

Authors:  Sadie van Esch; Anouk T N van Diepen; Dirk G Struijk; Raymond T Krediet
Journal:  Perit Dial Int       Date:  2014-11-13       Impact factor: 1.756

2.  Peritoneal albumin and protein losses do not predict outcome in peritoneal dialysis patients.

Authors:  Olga Balafa; Nynke Halbesma; Dirk G Struijk; Friedo W Dekker; Raymond T Krediet
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-11       Impact factor: 8.237

3.  Peritoneal Protein Clearance Is Associated With Cardiovascular Events but Not Mortality in Peritoneal Dialysis Patients.

Authors:  Wei Niu; Xiaoxiao Yang; Hao Yan; Zanzhe Yu; Zhenyuan Li; Xinghui Lin; Leyi Gu; Zhaohui Ni; Wei Fang
Journal:  Front Med (Lausanne)       Date:  2022-06-02

Review 4.  Relative Contributions of Pseudohypoxia and Inflammation to Peritoneal Alterations with Long-Term Peritoneal Dialysis Patients.

Authors:  Raymond T Krediet; Alena Parikova
Journal:  Clin J Am Soc Nephrol       Date:  2022-02-15       Impact factor: 10.614

5.  Intraperitoneal immunization of human subjects with tetanus toxoid induces specific antibody-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit a secretory IgA response.

Authors:  C Lue; A W van den Wall Bake; S J Prince; B A Julian; M L Tseng; J Radl; C O Elson; J Mestecky
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

6.  Does low peritoneal glucose load protect from the development of left ventricular hypertrophy in peritoneal dialysis patients?

Authors:  Kamal Hassan; Fadi Hassan; Dunia Hassan; Saab Anwar; Hassan Shadi
Journal:  Clin Exp Nephrol       Date:  2015-11-22       Impact factor: 2.801

7.  Good glycemic control is associated with better survival in diabetic patients on peritoneal dialysis: a prospective observational study.

Authors:  Dong Eun Yoo; Jung Tak Park; Hyung Jung Oh; Seung Jun Kim; Mi Jung Lee; Dong Ho Shin; Seung Hyeok Han; Tae-Hyun Yoo; Kyu Hun Choi; Shin-Wook Kang
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

8.  Impact of heavy proteinuria on clinical outcomes in patients on incident peritoneal dialysis.

Authors:  Seok Hui Kang; Kyu Hyang Cho; Jong Won Park; Kyung Woo Yoon; Jun Young Do
Journal:  BMC Nephrol       Date:  2012-12-17       Impact factor: 2.388

9.  The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients.

Authors:  Taner Basturk; Abdulkadir Unsal; Yener Koc; Eren Nezaket; Elbis Ahbap; Tamer Sakaci; Mustafa Sevinc
Journal:  Clinics (Sao Paulo)       Date:  2012-08       Impact factor: 2.365

10.  Peritoneal protein losses and cytokine generation in automated peritoneal dialysis with combined amino acids and glucose solutions.

Authors:  H L Tjiong; F J Zijlstra; T Rietveld; J L Wattimena; J G M Huijmans; G R Swart; M W J A Fieren
Journal:  Mediators Inflamm       Date:  2007       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.